Drug Type Small molecule drug |
Synonyms ADAM-9 inhibitor(Verra Therapeutics), VTH245 |
Target |
Action inhibitors |
Mechanism ADAM9 inhibitors(ADAM metallopeptidase domain 9 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lung Injury | Preclinical | United States | 04 Aug 2021 | |
Pulmonary Disease, Chronic Obstructive | Preclinical | United States | 16 Sep 2019 |